Related medicinesProtirelinTaltirelin

Where it comes from

Made in
The paraventricular nucleus of the hypothalamus; also widely through the brain and spinal cord
Sent out by
Cold, and the daily rhythm; thyroid hormone feeds back to stop it
Acts on
  • Pituitary thyrotrophs (TSH)
  • Lactotrophs (prolactin)
  • Brainstem and spinal cord (arousal, breathing)

What it does

  • Releases TSH, and so thyroid hormone
  • Releases prolactin from the lactotrophs, which is why a high TSH and a raised prolactin can turn up together 2
  • An arousal and antidepressant signal in the brain, independent of the thyroid

In medicine

  • The TRH stimulation test probed the pituitary before sensitive TSH assays; protirelin is now scarce 1
  • Taltirelin, a TRH analogue, is approved in Japan for spinocerebellar degeneration

Beyond the body’s own use

  • Rovatirelin, a later analogue from the same Japanese work, improved ataxia scores modestly against placebo in two phase 3 trials 3
  • TRH itself has been trialled in motor neuron disease, depression and epilepsy since the 1970s without a lasting result; a specific plasma enzyme destroys it within minutes, which is why resistant analogues were built 2
  • Nothing in the family is approved outside Japan, and TRH is not used outside medicine

Sources

  1. Protirelin (Thyrel TRH), FDA application NDA 018087
  2. Joseph-Bravo et al., TRH, the first hypophysiotropic releasing hormone isolated, Journal of Endocrinology 2015
  3. Nishizawa et al., Effect of rovatirelin in patients with cerebellar ataxia, Journal of Neurology Neurosurgery and Psychiatry 2020

This card describes what a medicine is for and what the evidence says; it recommends nothing. Talk to your clinician about anything you read here.